Daniel A. Franco

Family Medicine

490 Alabama St
Redlands, CA 92373

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer.

Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer.

Journal: Toxicology and applied pharmacology

Published: June 02, 2020

Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside-Containing Nanoliposomes.

Endothelial Immune Activation by Medin: Potential Role in Cerebrovascular Disease and Reversal by Monosialoganglioside-Containing Nanoliposomes.

Journal: Journal of the American Heart Association

Published: January 14, 2020

Novel approach to therapeutic targeting of castration-resistant prostate cancer.

Novel approach to therapeutic targeting of castration-resistant prostate cancer.

Journal: Medical hypotheses

Published: November 26, 2019

Amyloidogenic medin induces endothelial dysfunction and vascular inflammation through the receptor for advanced glycation endproducts.

Amyloidogenic medin induces endothelial dysfunction and vascular inflammation through the receptor for advanced glycation endproducts.

Journal: Cardiovascular research

Published: January 25, 2017

PEGylated-nanoliposomal clusterin for amyloidogenic light chain-induced endothelial dysfunction.

PEGylated-nanoliposomal clusterin for amyloidogenic light chain-induced endothelial dysfunction.

Journal: Journal of liposome research

Published: January 21, 2017

Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.

Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.

Journal: Molecules (Basel, Switzerland)

Published: January 16, 2017

Monosialoganglioside-Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins.

Monosialoganglioside-Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins.

Journal: Journal of the American Heart Association

Published: July 15, 2016

HDL inhibits saturated fatty acid mediated augmentation of innate immune responses in endothelial cells by a novel pathway.

HDL inhibits saturated fatty acid mediated augmentation of innate immune responses in endothelial cells by a novel pathway.

Journal: Atherosclerosis

Published: January 01, 2016

Oxidative Stress Alters the Morphology and Toxicity of Aortic Medial Amyloid.

Oxidative Stress Alters the Morphology and Toxicity of Aortic Medial Amyloid.

Journal: Biophysical journal

Published: June 16, 2015

Nanoliposomes protect against human arteriole endothelial dysfunction induced by β-amyloid peptide.

Nanoliposomes protect against human arteriole endothelial dysfunction induced by β-amyloid peptide.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: April 15, 2015

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.

Journal: Diabetes

Published: June 26, 2014

Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: a practical human model to study Alzheimer's disease vasculopathy.

Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: a practical human model to study Alzheimer's disease vasculopathy.

Journal: Journal of neuroscience methods

Published: December 12, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026